GC Wealth Management RIA’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.71M Sell
34,679
-8,309
-19% -$670K 0.16% 122
2026
Q1
$3.72M Buy
42,988
+562
+1% +$53.8K 0.15% 97
2025
Q4
$4.08M Sell
42,426
-17,261
-29% -$1.68M 0.15% 98
2025
Q3
$5.68M Buy
59,687
+26,118
+78% +$2.4M 0.19% 93
2025
Q2
$2.93M Buy
33,569
+5,734
+21% +$486K 0.24% 90
2025
Q1
$2.5M Buy
27,835
+1,692
+6% +$151K 0.46% 54
2024
Q4
$2.09M Buy
26,143
+4,145
+19% +$359K 0.37% 65
2024
Q3
$1.98M Buy
21,998
+4,399
+25% +$370K 0.35% 64
2024
Q2
$1.39M Buy
17,599
+3,906
+29% +$320K 0.27% 75
2024
Q1
$1.19M Buy
13,693
+4,993
+57% +$426K 0.24% 83
2023
Q4
$717K Buy
+8,700
New +$663K 0.32% 81

Other funds holding MDT

GC Wealth Management RIA's MDT Position: Q2 2026 in Review

GC Wealth Management RIA reduced its Medtronic (MDT) stake by 19% in Q2 2026, selling an estimated $670K and leaving 34,679 shares worth $2.71M. The position accounts for 0.16% of the portfolio, ranked #122.

GC Wealth Management RIA first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.68M in Q3 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • GC Wealth Management RIA held 34,679 shares of Medtronic worth $2.71M as of Q2 2026.
  • GC Wealth Management RIA sold 8,309 Medtronic shares in Q2 2026, an estimated $670K.
  • Medtronic made up 0.16% of GC Wealth Management RIA's portfolio in Q2 2026, its #122 holding.
  • GC Wealth Management RIA first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • GC Wealth Management RIA's Medtronic position peaked at $5.68M in Q3 2025.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on GC Wealth Management RIA's 13F filing for Q2 2026, filed 16 Jul 2026.